For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Osteoarthritis - Independent medicine & health information for consumers & professionals Osteoarthritis
Show health professional infoLatest independent information about osteoarthritis, including medicines and non-drug treatments, written and reviewed by experts in Australia.
Osteoarthritis is also known as arthritis (osteoarthritis).
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience  |
Date* |
|---|---|---|---|---|
Benefit and risk to be balanced with new COX-2 |
NPS has just released a review of lumiracoxib (Prexige) in the independent drug newsletter, NPS RADAR. |
Media release | Others | 2006-08-01 00:00:00 |
Case study 17 report: COX-2 selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol. |
Professional activity - Case study report | Health Professionals | 2001-10-01 00:00:00 |
Case study 17: COX-2 selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol. |
Professional activity - Case study | Health Professionals | 2001-10-01 00:00:00 |
Case study 44 Report: Selecting analgesics |
Elderly patient requests 'something stronger' for worsening osteoarthritis of the knees. Has been taking paracetamol and meloxicam but knee pain has increased in last few months. |
Professional activity - Case study report | Health Professionals | 2006-10-01 00:00:00 |
Case study 44: Selecting analgesics |
Elderly patient requests 'something stronger' for worsening osteoarthritis of the knees. Has been taking paracetamol and meloxicam but knee pain has increased in last few months. |
Professional activity - Case study | Health Professionals | 2006-08-01 00:00:00 |
Case study 9 report: COX-2 selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol. |
Professional activity - Case study report | Health Professionals | 2000-07-01 00:00:00 |
Case Study 9 : COX-2-selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol |
Professional activity - Case study report | Health Professionals | 2000-07-01 00:00:00 |
Case study PH4 report: For pharmacists. COX-2 selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with increased joint pain previously well controlled with paracetamol. He asks about the new drug for arthritis. |
Professional activity - Case study report | Health Professionals | 2002-02-01 00:00:00 |
Case study PH4: For pharmacists. COX-2 selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with increased joint pain previously well controlled with paracetamol. He asks about the new drug for arthritis. |
Professional activity - Case study | Health Professionals | 2001-10-01 00:00:00 |
Glucosamine and chondroitin in osteoarthritis |
A review of available evidence on the efficacy and adverse effects associated with the use of glucosamine and chondroitin (individually and in combination) in osteoarthritis. |
Professional publication - NPS factsheet | Health Professionals | 2003-10-28 00:00:00 |
Lumiracoxib (Prexige) for osteoarthritis |
Reports urgent withdrawal of lumiracoxib by TGA because of serious liver adverse effects and includes review of lumiracoxib use for osteoarthritis. |
Professional publication - NPS RADAR - Review | Health Professionals | 2006-08-01 00:00:00 |
Managing osteoarthritis pain |
Learn about analgesic and anti-inflammatory medicines for managing the pain of osteoarthritis. |
Consumer publication - MedicinesTalk | Consumers | 2007-06-01 00:00:02 |
Lumiracoxib (Prexige) for osteoarthritis |
Since this issue of Medicine Update was published, lumiracoxib (Prexige) has been withdrawn by the Therapeutic Goods Administration. |
Consumer publication - Medicine Update | Consumers | 2007-04-01 00:00:00 |
MedicinesTalk No. 22 Winter 2007 edition |
MedicinesTalk Winter 2007, containing buying medicines over the internet, moving on with chronic illness, managing the pain of osteoarthritis and what's in a name. |
Consumer publication - MedicinesTalk | Consumers | 2007-06-01 00:00:00 |
New COX-2: benefit and heart risk to be balanced |
A review of lumiracoxib (Prexige), which helps prescribers to assess the balance of risks and benefits for individual patients, is in the latest edition of NPS RADAR. |
Media release | Others | 2006-08-01 00:00:00 |
Osteoarthritis and COX-2 inhibitors |
How safe are COX-2 selective NSAIDs in osteoarthritis? Are there adverse effects and drug interactions? What about glucosamine? |
Professional publication - NPS News | Health Professionals | 2001-10-01 00:00:00 |
NPS News 2: Pain management using anti-inflammatory drugs and herbs |
Anti-inflammatory drugs (NSAIDs) and herbs used in managing pain. Discusses gastrointestinal complications reduced by misoprostol and includes a brief report on case study 1. |
Professional publication - NPS News | Health Professionals | 1999-02-01 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2010-12-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
